- Home
- GRPN vs ATTO Comparison
GRPN vs ATTO Comparison
Compare GRPN & ATTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRPN | ATTO |
|---|---|---|
| Founded | 2008 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2011 | 2026 |
Fundamental Metrics
Financial Performance| Metric | GRPN | ATTO |
|---|---|---|
| Price | $18.80 | $16.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $28.67 | ★ $42.20 |
| AVG Volume (30 Days) | ★ 994.5K | 367.7K |
| Earning Date | 11-05-2026 | 09-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,843,877,000.00 | N/A |
| Revenue This Year | $4.06 | N/A |
| Revenue Next Year | $8.03 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.17 | $15.48 |
| 52 Week High | $29.90 | $28.00 |
Technical Indicators
Market Signals| Indicator | GRPN | ATTO |
|---|---|---|
| Relative Strength Index (RSI) | 43.37 | 36.53 |
| Support Level | $15.92 | $16.39 |
| Resistance Level | $18.85 | $18.38 |
| Average True Range (ATR) | 0.97 | 1.33 |
| MACD | -0.07 | -0.26 |
| Stochastic Oscillator | 25.67 | 16.64 |
Price Performance
Historical ComparisonAbout GRPN Groupon Inc.
Groupon Inc is a globalised, scaled two-sided marketplace that connects consumers to merchants. Its categories include Local: local inventory includes things to do, beauty and wellness, food and drink, home and automotive services, online services, as well as other types of experiences and services. Goods: Includes merchandise across multiple product lines, such as electronics, sporting goods, jewelry, toys, household items and apparel, and Travel: Features travel experiences at both discounted and market rates, including hotels, airfare, and package deals covering both domestic and international travel. The company operates in two segments, North America and International, with the majority of revenue from the Local category from the North America Segment.
About ATTO Attovia Therapeutics Inc. Common Stock
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.